Feed aggregator

eCR Now: COVID-19 Electronic Case Reporting

2019 Novel Coronavirus (CDC) - Fri, 11/13/2020 - 07:00
Electronic Case Reporting (eCR) is the automated generation and transmission of case reports from the electronic health record (EHR) to public health agencies for review and action. eCR makes disease reporting from healthcare to public health faster and easier. eCR Now allows for rapid adoption and implementation of eCR for COVID-19, enabling real-time tracking.
Categories: C.D.C. (U.S.)

An Approach for Monitoring and Evaluating Community Mitigation Strategies for COVID-19

2019 Novel Coronavirus (CDC) - Fri, 11/13/2020 - 07:00
CDC's approach to evaluating community mitigation strategies and provides overarching considerations.
Categories: C.D.C. (U.S.)

Meat and Poultry Processing Facility Assessment Toolkit

2019 Novel Coronavirus (CDC) - Fri, 11/13/2020 - 07:00
Tools and resources for occupational safety and health professionals and state and local public health officials assessing meat and poultry processing facilities.
Categories: C.D.C. (U.S.)

Schools and Childcare Programs

2019 Novel Coronavirus (CDC) - Fri, 11/13/2020 - 07:00
Schools & Childcare: Guidance for School Settings
Categories: C.D.C. (U.S.)

Community, Work, and School

2019 Novel Coronavirus (CDC) - Fri, 11/13/2020 - 07:00
Preventing COVID-19 spread in schools, workplaces, and communities.
Categories: C.D.C. (U.S.)

Open Burning during the COVID-19 Pandemic

2019 Novel Coronavirus (CDC) - Fri, 11/13/2020 - 07:00
This document describes the public health risks of open burning, strategies to reduce smoke exposures during the COVID-19 pandemic, and resources that health officials, environmental health professionals, fire managers, and others can refer to when creating or adapting existing plans to manage open burning during the pandemic.
Categories: C.D.C. (U.S.)

Frequently Asked Questions about COVID-19 Vaccination

2019 Novel Coronavirus (CDC) - Fri, 11/13/2020 - 07:00
Answers to commonly asked questions about COVID-19 vaccines, including vaccine cost, availability, and types.
Categories: C.D.C. (U.S.)

Healthcare Facilities That Have Implemented COVID-19 Electronic Case Reporting

2019 Novel Coronavirus (CDC) - Fri, 11/13/2020 - 07:00
Healthcare Facilities That Have Implemented COVID-19 Electronic Case Reporting
Categories: C.D.C. (U.S.)

Clinical decision algorithm to guide care advice messages

2019 Novel Coronavirus (CDC) - Fri, 11/13/2020 - 07:00
Describes flowchart algorithm to guide care advice messages on interim COVID-19 phone advice line
Categories: C.D.C. (U.S.)

Late Sequelae of COVID-19

2019 Novel Coronavirus (CDC) - Fri, 11/13/2020 - 07:00
Late Sequelae of COVID-19
Categories: C.D.C. (U.S.)

Airport Personnel and COVID-19

2019 Novel Coronavirus (CDC) - Fri, 11/13/2020 - 07:00
Airport Personnel and COVID-19
Categories: C.D.C. (U.S.)

Monitoring and Evaluating Covid-19 Mitigation Strategies in K-12 Schools: Interview Guide

2019 Novel Coronavirus (CDC) - Fri, 11/13/2020 - 07:00
This interview guide is meant to be adaptable for your local context. This tool is meant to help the interviewer obtain more in-depth information about perceptions and experiences of mitigation strategies used to reduce the spread of COVID-19 when schools are in in-person learning mode. The tool is intended for government professionals in public health or education, school district administrators, and administrators of K-12 schools who are interested in conducting their own data collection.
Categories: C.D.C. (U.S.)

Monitoring and Evaluating Covid-19 Mitigation Strategies In K-12 Schools: Focus Group Guide

2019 Novel Coronavirus (CDC) - Fri, 11/13/2020 - 07:00
This focus group guide contains sections that are adaptable for your local context. This tool is intended to help the moderator obtain more in-depth information about perceptions and experiences of mitigation strategies used to reduce the spread of COVID-19 when schools are in in-person learning mode. The tool is intended for government professionals in public health or education, school district administrators, or administrators of K-12 schools who are interested in conducting their own data collection.
Categories: C.D.C. (U.S.)

What Rideshare, Taxi, Limo, and other Passenger Drivers-for-Hire Need to Know about COVID-19

2019 Novel Coronavirus (CDC) - Fri, 11/13/2020 - 07:00
Learn what rideshare drivers and other passenger drivers-for-hire need to know during COVID-19.
Categories: C.D.C. (U.S.)

Monitoring and Evaluating Mitigation Strategies in Child Care Programs

2019 Novel Coronavirus (CDC) - Fri, 11/13/2020 - 07:00
Use CDC's resources to monitor and evaluate your COVID-19 prevention and control strategies. Results can help you adjust your strategies to reduce the spread of COVID-19.
Categories: C.D.C. (U.S.)

Information for School Nurses and Other Healthcare Personnel (HCP) Working in Schools and Child Care Settings

2019 Novel Coronavirus (CDC) - Fri, 11/13/2020 - 07:00
Information and resources for school nurses and other healthcare personnel working in schools and child care settings during the COVID-19 pandemic.
Categories: C.D.C. (U.S.)

Rift Valley Fever – Mauritania

Disease outbreak news - Fri, 11/13/2020 - 02:00
The Ministry of Health (MoH) notified WHO that between 13 September and 1 October 2020, eight cases of Rift Valley Fever (RVF) including seven deaths were confirmed in animal breeders. Districts affected include Tidjikja and Moudjéria (Tagant region), Guerou (Assaba region) and Chinguetty (Adrar region). Laboratory confirmation of RVF infection was performed using a reverse transcription polymerase chain reaction (RT-PCR) at the National Institute for Public Health Research (INRSP) in Nouakchott. The age of infected patients varied between 16 and 70 years old and included one woman and seven men. All seven deaths occurred among hospitalised patients with fever and haemorrhagic syndrome (petechia, gingivorrhagia) and vomiting.

Between 4 September and 7 November 2020, a total of 214 people were sampled and their samples have been sent to the INRSP for laboratory testing with a total of 75 testing positive for RVF (RT-PCR and serology by enzyme-linked immunosorbent assay (ELISA). Positive cases have been reported in 11 of 15 regions of the country: Brakna, Trarza, Gorgol, (on the border with Senegal), Adrar, Assaba, Hodh El Gharby, Hodh El Chargui, Guidimaka (on the border with Mali) and Nouakchott Sud, Nouakchott Ouest and Tagant. The Tagant region is the most affected (38/75, 51%) with principal hotspot districts being Tidjikja and Moudjeria. Thus far a total of 25 deaths have been reported from this outbreak.

Worldwide measles deaths climb 50% from 2016 to 2019 claiming over 207 500 lives in 2019

WHO news - Thu, 11/12/2020 - 20:00

Measles surged worldwide in 2019 reaching highest number of reported cases in 23 years. Highlighted in a publication by WHO and the United States Centers for Disease Control and Prevention (CDC), measles cases worldwide increased to 869 770 in 2019, the highest number reported since 1996 with increases in all WHO regions. Global measles deaths climbed nearly 50 percent since 2016, claiming an estimated 207 500 lives in 2019 alone. 

After steady global progress from 2010 to 2016, the number of reported measles cases climbed progressively to 2019. Comparing 2019 data with the historic low in reported measles cases in 2016, authors cite a failure to vaccinate children on time with two doses of measles-containing vaccines (MCV1 and MCV2) as the main driver of these increases in cases and deaths.

“We know how to prevent measles outbreaks and deaths,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “These data send a clear message that we are failing to protect children from measles in every region of the world. We must collectively work to support countries and engage communities to reach everyone, everywhere with measles vaccine and stop this deadly virus.”

Measles outbreaks occur when people who are not protected from the virus are infected and spread the disease to unvaccinated or under-vaccinated populations. To control measles and prevent outbreaks and deaths, vaccination coverage rates with the required MCV1 and MCV2 must reach 95 percent and be maintained at national and subnational levels.  MCV1 coverage has been stagnant globally for more than a decade at between 84 and 85 percent. MCV2 coverage has been steadily increasing but is only now at 71 percent. Vaccination coverage against measles remains well below the 95 percent or higher needed with both doses to control measles and prevent outbreaks and deaths.

Global response to COVID-19 pandemic must not exacerbate the measles crisis

Although reported cases of measles are lower in 2020, necessary efforts to control COVID-19 have resulted in disruptions in vaccination and crippled efforts to prevent and minimize measles outbreaks. As of November, more than 94 million people were at risk of missing vaccines due to paused measles campaigns in 26 countries. Many of these countries are experiencing ongoing outbreaks. Of countries with postponed planned 2020 campaigns, only eight (Brazil, Central African Republic, Democratic Republic of Congo, Ethiopia, Nepal, Nigeria, Philippines and Somalia) resumed their campaigns after initial delays. 

“Before there was a coronavirus crisis, the world was grappling with a measles crisis, and it has not gone away,” said Henrietta Fore, UNICEF Executive Director. “While health systems are strained by the COVID-19 pandemic, we must not allow our fight against one deadly disease to come at the expense of our fight against another. This means ensuring we have the resources to continue immunization campaigns for all vaccine-preventable diseases, even as we address the growing COVID-19 pandemic.”

Causes of failure to control measles are many and must be addressed

Global immunization partners are engaging leaders and public health professionals in affected and at-risk countries to ensure that measles vaccines are available and safely delivered, and that caregivers understand the life-saving benefit of the vaccine. On 6 November 2020, WHO and UNICEF issued an emergency call to action for measles and polio outbreak prevention and response.

“Measles virus easily finds unprotected children, adolescents and adults because it is so contagious,” said Dr. Robert Linkins, Measles & Rubella Initiative Management Team Chair and Accelerated Disease Control Branch Chief at U.S. CDC. “Infections are not only a sign of poor measles vaccination coverage, but also a known marker, or ‘tracer,’ that vital health services may not be reaching populations most at-risk. Our collective efforts to reach children with vaccines now, ahead of the possible easing of COVID-19 travel restrictions and increased population movement, will save lives.”

The Measles & Rubella Initiative (M&RI), which includes American Red Cross, the United Nations Foundation, the U.S. CDC, UNICEF and WHO, and global immunization partners like Gavi, the Vaccine Alliance, the Bill and Melinda Gates Foundation and others, are working to address the current measles crisis and ensure that resources are positioned to address immunization delays – for measles and all vaccines – in every region of the world. A bold strategy released by M&RI, Measles & Rubella Strategic Framework 2021 – 2030, will help to address reversals in global progress toward measles elimination by bolstering strong, national immunization systems that can reach and protect children. This strategic shift by the partnership will focus on strengthening the routine delivery of all vaccines, and quickly and effectively detecting and responding to measles outbreaks.

Quotes from our partners

“These alarming figures should act as a warning that, with the COVID-19 pandemic occupying health systems across the world, we cannot afford to take our eye off the ball when it comes to other deadly diseases. Measles is entirely preventable; in a time in which we have a powerful, safe and cost-effective vaccine nobody should still be dying of this disease. COVID-19 has resulted in dangerous declines in immunization coverage, leading to increased risk of measles outbreaks. This is why countries urgently need to prioritize measles catch-up immunization through routine services to mitigate the risk of outbreaks and ensure no child goes without this lifesaving vaccine.” - Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance.

“The fact that measles outbreaks are occurring at the highest levels we’ve seen in a generation is unthinkable when we have a safe, cost-effective, and proven vaccine. No child should die from a vaccine-preventable disease. We are proud to chart a bold way forward with partners to close gaps in access to immunization and rapidly respond to outbreaks so everyone, everywhere can live healthy lives.” - Elizabeth Cousens, President & CEO, United Nations Foundation.

“We are concerned that COVID-19 will contribute to an increase in the number of measles cases and deaths. Measles knows no borders, and it is imperative we work together to vaccinate more children and continue the fight against this preventable disease. “Around the globe, Red Cross and Red Crescent volunteers help families in chronically unvaccinated communities to protect their children. Join us in this effort.” - Gail McGovern, President & CEO of the American Red Cross.

###

Notes to editors

Download photos and broll on vaccines here: https://weshare.unicef.org/Package/2AM408X1UA6X

About M&RI:

The Measles & Rubella Initiative (M&RI) is a partnership between the American Red Cross, the United Nations Foundation, the U.S. CDC, UNICEF and WHO. Working with Gavi, the Vaccine Alliance and other stakeholders, the Initiative is committed to achieving and maintaining a world without measles, rubella and congenital rubella syndrome. Since 2000, M&RI has helped deliver over USD 5.5 billion doses of measles vaccine to children worldwide and saved over USD 25.5 million lives by increasing vaccination coverage, responding to outbreaks, monitoring and evaluation, and supporting demand for vaccine.  

More information on measles:

WHO factsheet; CDC measles updates; Latest WHO measles surveillance data; UNICEF’s immunization updates; and Latest WHO guidelines for immunization programme in context of COVID-19.

 

Neglected tropical diseases: World Health Assembly endorses bold new road map targets for 2030

WHO news - Thu, 11/12/2020 - 14:29
Although medicines used for neglected tropical diseases (NTDs) continue to effective, antimicrobial resistance can compromise these global programmes. To ensure drug-efficacy, immediate measures - including monitoring and establishment of surveillance systems - need to be in place. To mark this year’s World Antimicrobial Awareness Week from 18 -24 November, the NTD Department and the Department of Global Coordination and Partnership on AMR are hosting a webinar on 24 November.

Rapid Risk Assessment: Detection of new SARS-CoV-2 variants related to mink

ECDC - Risk assessments - Thu, 11/12/2020 - 14:00
This assessment considers the risk to human health posed by SARS-CoV-2 mink related variants. It is based on information available to ECDC at the time of publication and, unless otherwise stated, the assessment of risk refers to the risk that existed at the time of writing.
Categories: C.D.C. (Europe)

Pages

Subscribe to Brain Association Iasi aggregator